|
Fibrinogen/fibrin
Citations 11-20 of 54 total displayed.
|
Past content
(since May 2001):
|
- Vascular Medicine
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation 2006;114:2490-2497; published online before print as doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
[Full text]
- Articles
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology. A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation published November 13, 2006, doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
- Epidemiology
Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events
- Samia Mora, Nader Rifai, Julie E. Buring, and Paul M Ridker
Circulation 2006;114:381-387; published online before print as doi:10.1161/CIRCULATIONAHA.106.634089
[Abstract]
[Full text]
- Articles
Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events
- Samia Mora, Nader Rifai, Julie E. Buring, and Paul M Ridker
Circulation published July 24, 2006, doi:10.1161/CIRCULATIONAHA.106.634089
[Abstract]
- Images in Cardiovascular Medicine
Architecture of Intracoronary Thrombi in ST-Elevation Acute Myocardial Infarction: Time Makes the Difference
- Farzin Beygui, Jean-Philippe Collet, Chandrasekaran Nagaswami, John W. Weisel, and Gilles Montalescot
Circulation 2006;113:e21-23e, doi:10.1161/CIRCULATIONAHA.105.551705
[Full text]
- Imaging
Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent
- Marc Sirol, Valentin Fuster, Juan J. Badimon, John T. Fallon, Jean-François Toussaint, and Zahi A. Fayad
Circulation 2005;112:1594-1600; published online before print as doi:10.1161/CIRCULATIONAHA.104.522110
[Abstract]
[Full text]
- Articles
Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent
- Marc Sirol, Valentin Fuster, Juan J. Badimon, John T. Fallon, Pedro R. Moreno, Jean-François Toussaint, and Zahi A. Fayad
Circulation published September 6, 2005, doi:10.1161/CIRCULATIONAHA.104.522110
[Abstract]
- Imaging
Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent
- Elmar Spuentrup, Arno Buecker, Marcus Katoh, Andrea J. Wiethoff, Edward C. Parsons, Jr, Rene M. Botnar, Robert M. Weisskoff, Philip B. Graham, Warren J. Manning, and Rolf W. Günther
Circulation 2005;111:1377-1382; published online before print as doi:10.1161/01.CIR.0000158478.29668.9B
[Abstract]
[Full text]
- Articles
Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent
- Elmar Spuentrup, Arno Buecker, Marcus Katoh, Andrea J. Wiethoff, Edward C. Parsons, Jr, Rene M. Botnar, Robert M. Weisskoff, Philip B. Graham, Warren J. Manning, and Rolf W. Günther
Circulation published February 28, 2005, doi:10.1161/01.CIR.0000158478.29668.9B
[Abstract]
- AHA Conference Proceedings
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Disclosure
-
Circulation 2004;110:e577-578e, doi:10.1161/01.CIR.0000152612.25993.04
[Full text]
|
|
